image
Intellia Therapeutics, Inc. NTLA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.415
-4.86 %
$ 975 M
Market Cap
-1.76
P/E
Price Target Average
311.20%
Revenue Forecast Estimate
151.59%
EBIT Estimate
--44.34%
Net Income Estimate
41.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Intellia Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for NTLA of $38.7 , with forecasts ranging from a low of $9 to a high of $80 .
NTLA Lowest Price Target Wall Street Target
9 USD -4.41%
NTLA Average Price Target Wall Street Target
38.7 USD 311.20%
NTLA Highest Price Target Wall Street Target
80 USD 749.71%
Price
Max Price Target
Min Price Target
Average Price Target
8080707060605050404030302020101000Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart NTLA

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NTLA

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NTLA

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029